BRIACELL THERAP (BCTX) vs Prima BioMed Ltd (IMMP)

BRIACELL THERAP and Prima BioMed Ltd are both Biotechnology companies. BRIACELL THERAP and Prima BioMed Ltd are of similar size ($38.5M and $37.2M). Prima BioMed Ltd has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.9×. Across the 10 metrics below, BRIACELL THERAP leads on 5 and Prima BioMed Ltd on 5.

Valuation

Metric BCTX IMMP Biotechnology median
P/E 1.94 n/m 7.88
P/S n/m n/m 11.47
P/B 1.34 0.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield 51.65% (40.42%) (28.84%)
Free cash flow yield (100.28%) (181.72%) (23.03%)

Profitability

Metric BCTX IMMP Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (173.55%) 0.00% (57.72%)
Return on assets (139.20%) 0.00% (49.22%)
Return on invested capital (3,311.00%) 0.00% 0.00%

Growth

Metric BCTX IMMP Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (43.04%) (37.04%) —
Revenue growth, 5-year CAGR — 40.79% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX IMMP Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 7.07 2.97 4.73
Net debt to EBITDA 0.66 0.92 0.96

Dividend

Metric BCTX IMMP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BCTX IMMP Biotechnology median
Market cap 37.24m 38.48m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack